Neurelis, Inc., today announced that the U.S. Food and Drug Administration (FDA) has approved VALTOCO® (diazepam nasal spray) ...

Decongestant sprays shouldn't be used for more than a week - but those who don't realise can become trapped in a cycle of ...

In this younger patient population, diazepam nasal spray was readily absorbed and demonstrated a consistent PK profile with that of older children and adults aged 6 to 59 years.

Decongestant sprays shouldn't be used for more than a week - but those who don't realise can become trapped in a cycle of ...

Milestone Pharmaceuticals said on Friday the U.S. health regulator had declined to approve its nasal spray to treat a type of heart condition and had called for an inspection of the facility that ...

The company had previously expected to launch the nasal spray, Cardamyst, in mid-2025. The U.S. Food and Drug Administration, in its so-called complete response letter, has also sought additional ...

This is great news, but families can't just hand over the nasal spray form to their school nurse. The Texas law allowing school nurses to give epinephrine uses the phrase "auto-injectors" when ...

The U.S. Food and Drug Administration has declined to approve Milestone Pharmaceuticals' nasal spray to treat a type of heart condition, the company said on Friday. The health regulator did not raise ...

A nasal spray, referred to as nasal anti-CD3, could be the first FDA-approved treatment for traumatic brain injury, or TBI, that can be easily administered with no serious side effects ...

Nagpur: Researchers from Nagpur University's postgraduate department of pharmaceutical sciences have developed a new ...

The U.S. Food and Drug Administration (FDA) has approved the use of a nasal spray as a standalone treatment for major depressive disorder, offering a new option for those struggling with treatment ...